Clinical Trials in Massachusetts

Showing 1081-1100 of 15,316 trials

A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa

NCT07016750

KB803-EYE-01 is a Phase 3 double-blind, randomized, placebo-controlled, crossover study to evaluate the safety and efficacy of KB803 versus matched placebo in pediatric and adult subjects with recurrent corneal abrasions due to dystrophic epidermolysis bullosa (DEB).

Dystrophic Epidermolysis BullosaDEB - Dystrophic Epidermolysis BullosaRecessive Dystrophic Epidermolysis Bullosa+1 more

Krystal Biotech, Inc.16 participantsStarted Jun 2025

Rancho Santa Margarita, California, United States • Coral Gables, Florida, United States • Worcester, Massachusetts, United States +2 more locations

RECRUITINGNA14 miles

CLEANer Aspiration for Pulmonary Embolism

NCT06189313

To evaluate the safety and efficacy of the Cleaner™ Pro Thrombectomy System for aspiration thrombectomy in patients with acute pulmonary embolism (PE).

Pulmonary EmbolismAcute Pulmonary EmbolismCardiovascular Diseases+1 more

Argon Medical Devices125 participantsStarted Jan 2025

Aurora, Colorado, United States • Washington D.C., District of Columbia, United States • Pensacola, Florida, United States +11 more locations

A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa

CLEANer Aspiration for Pulmonary Embolism

Find Trials by Condition in Massachusetts

Sulfasalazine for the Treatment of Primary Sclerosing Cholangitis

Healthy And Positive Pathways for Young People With Type 1 Diabetes (HAPPY T1D)

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

Improving the Quality of Care for Asthma Patients at Risk of Exacerbations

A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Linezolid for Syphilis Pilot Study

Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight

A Study of miRNA 371 in Patients With Germ Cell Tumors

Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors

Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease